[HTML][HTML] Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor

…, CH Liu, TL Macdonald, KR Lynch, CY Lin… - Journal of Biological …, 2007 - ASBMB
Sphingosine 1-phosphate (S1P), a multifunctional lipid mediator, regulates lymphocyte
trafficking, vascular permeability, and angiogenesis by activation of the S1P 1 receptor. This …

[HTML][HTML] Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease

SL Lee, RB Dickson, CY Lin - Journal of Biological Chemistry, 2000 - ASBMB
Matriptase is an epithelial-derived, integral membrane serine protease. The enzyme was
initially isolated from human breast cancer cells and has been implicated in breast cancer …

A potential marker protease of invasiveness, separase, is localized on invadopodia of human malignant melanoma cells

WL Monsky, CY Lin, A Aoyama, T Kelly, SK Akiyama… - Cancer research, 1994 - AACR
Seprase, a large, gelatin-degrading membrane-protease complex, is expressed at the invasive
front of malignant melanoma cells on invadopodia, and its surface expression contributes …

[HTML][HTML] Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk

CY Lin, J Anders, M Johnson, RB Dickson - Journal of Biological Chemistry, 1999 - ASBMB
Matriptase, a trypsin-like serine protease with two potential regulatory modules (low density
lipoprotein receptor and complement C1r/s domains), was initially purified from T-47D breast …

Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in …

JY Kang, M Dolled-Filhart, IT Ocal, B Singh, CY Lin… - Cancer research, 2003 - AACR
Numerous studies have demonstrated that overexpression of Met, the hepatocyte growth
factor(HGF) receptor, plays an important role in tumorigenesis. Met activation can either occur …

[HTML][HTML] Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity

CY Lin, J Anders, M Johnson, QA Sang… - Journal of Biological …, 1999 - ASBMB
A major protease from human breast cancer cells was previously detected by gelatin
zymography and proposed to play a role in breast cancer invasion and metastasis. To structurally …

[HTML][HTML] TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is …

…, JK Wang, TM Antalis, MD Johnson, CY Lin - The American journal of …, 2010 - Elsevier
TMPRSS2, a type II transmembrane serine protease, is highly expressed by the epithelium
of the human prostate gland. To explore the regulation and function of TMPRSS2 in the …

[HTML][HTML] The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor

…, CA Williams, RB Dickson, MD Johnson, CY Lin - Journal of Biological …, 2003 - ASBMB
The activation of matriptase requires proteolytic cleavage at a canonical activation motif that
converts the enzyme from a one-chain zymogen to an active, two-chain protease. In this …

Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological …

MD Oberst, MD Johnson, RB Dickson, CY Lin… - Clinical cancer …, 2002 - AACR
Purpose: Matriptase is a type II transmembrane serine protease expressed by cells of surface
epithelial origin, including epithelial ovarian tumor cells. Matriptase cleaves and activates …

[HTML][HTML] Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation

S Netzel-Arnett, BM Currie, R Szabo, CY Lin… - Journal of Biological …, 2006 - ASBMB
Recent gene ablation studies in mice have shown that matriptase, a type II transmembrane
serine protease, and prostasin, a glycosylphosphatidylinositol-anchored membrane serine …